YUKEN NSI Week ended 07 Aug 2026

Weekly Investor Report

Yuken India Limited · Industrials · Specialty Industrial Machinery

Open interactive chart View report data
Latest close 800.0 INR
11.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 9.8% above the Trend Line and sits at 46.1% of its 52-week range. The latest completed week returned 11.3%, after a 3.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 41/100.

Setup score 51 out of 100
Latest Close 800.0 INR 7 Aug 2026
1W Return 11.3% latest completed week
4W Return 3.5% short-term follow-through
12W Return 16.4% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 2.9x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 11.3% Latest completed week; four-week move 3.5%. Indicator stack 8/65 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Buy Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 41/100 14 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 9.8% above the Trend Line and sits at 46.1% of its 52-week range. The latest completed week returned 11.3%, after a 3.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2712-week average 0.24

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.27Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.5% over four weeks, 16.4% over 12 weeks, and -20.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W11.3%
4W3.5%
12W16.4%
26W1.1%
52W-20.9%
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.88Latest activity-pressure read.
Pressure change-7.9%Four-week change in activity pressure.
Leadership-0.70Latest relative-leadership reading.
RS change87.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength5/100Blend of value, momentum, and quality. Underlying universe rank 96; rank 1 is best.
Value23/100Relative valuation strength. Underlying universe rank 78; rank 1 is best.
Quality23/100Profitability and accounting quality. Underlying universe rank 78; rank 1 is best.
Momentum18/100Medium-term price momentum. Underlying universe rank 83; rank 1 is best.
Growth8/100Revenue and earnings growth. Underlying universe rank 93; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework15/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
75.1x
Price divided by trailing earnings.
Price / sales
2.4x
Market value relative to trailing revenue.
EV / EBITDA
21.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-3.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
54.0%
Gross profit retained from each unit of revenue.
Operating margin
6.3%
Operating profit retained from revenue.
Free-cash-flow margin
-9.0%
Free cash flow generated from revenue.
Return on invested capital
4.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.1%
Latest one-year revenue growth.
EPS growth
-43.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.2%
Cash dividends relative to market value.
Buyback yield
-5.5%
Net share repurchases relative to market value.
Shareholder yield
-5.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment41/100

Weighted news tone is neutral across 14 relevant articles.

0 positive · 10 neutral · 4 negative
Patient CapitalFresh

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Fresh buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-24.0%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+14.1%Week of 10 Apr.
Worst week-8.3%Week of 27 Mar.
Latest week+11.3%Week of 7 Aug.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses5
Sharp losses8
Recent vol4.9%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape45/100

Trend, activity pressure, participation, and risk combine to a 45/100 tape read.

 Indicator analysis34/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.27; No reversal markers Factors16/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 90; Small Cap Core rank 81 SVQF15/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 1339.5 of 1576 Patient CapitalFresh

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Fresh buy signal Sentiment41/100

Weighted news tone is neutral across 14 relevant articles.

Yuken India Ltd Technical Momentum Shifts Amid Bearish Market Sentiment Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026800.0 INR11.3%728.4 INR915.5 INR0.88-0.7096.9KOff
31 Jul 2026718.9 INR1.5%729.5 INR914.4 INR0.84-10.5630.3KOff
24 Jul 2026708.2 INR-4.2%735.0 INR913.8 INR1.00-10.3245.1KOff
17 Jul 2026739.5 INR-4.3%740.0 INR913.3 INR1.09-9.2848.8KOff
10 Jul 2026773.0 INR-1.2%743.4 INR912.6 INR0.95-5.4449.2KOff
3 Jul 2026782.5 INR4.5%746.0 INR911.6 INR0.72-5.2114.9KOff
26 Jun 2026749.0 INR8.2%748.3 INR910.7 INR0.44-9.030Off
19 Jun 2026692.5 INR1.1%753.1 INR910.1 INR0.37-16.444.0KOff
12 Jun 2026685.0 INR0.1%759.5 INR909.5 INR0.29-16.7713.0KOff
5 Jun 2026684.4 INR-1.6%766.4 INR909.0 INR0.26-16.583.4KOff
29 May 2026695.8 INR4.9%774.5 INR908.6 INR0.35-16.4563.5KOff
22 May 2026663.2 INR-3.5%784.2 INR908.0 INR0.39-21.4741.1KOff
15 May 2026687.3 INR-5.5%792.9 INR907.6 INR0.40-19.0623.6KOff
8 May 2026727.3 INR-3.6%801.0 INR907.0 INR0.41-16.6534.8KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context